|Year : 2023 | Volume
| Issue : 1 | Page : 250
Resolution of cilioretinal artery occlusion with central retinal vein occlusion
Seung Min Lee, Hansang Lee, Min Kim
Department of Ophthalmology, Institute of Vision Research, Gangnam Severance Hospital, Yonsei University, College of Medicine, Gangnam-Gu, Seoul, Republic of Korea
|Date of Web Publication||20-Jan-2023|
Department of Ophthalmology, Institute of Vision Research, Gangnam Severance Hospital, Yonsei University, College of Medicine, Eonjuro 211, Gangnam-Gu, Seoul, 06273
Republic of Korea
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Lee SM, Lee H, Kim M. Resolution of cilioretinal artery occlusion with central retinal vein occlusion. Indian J Ophthalmol Case Rep 2023;3:250
|How to cite this URL:|
Lee SM, Lee H, Kim M. Resolution of cilioretinal artery occlusion with central retinal vein occlusion. Indian J Ophthalmol Case Rep [serial online] 2023 [cited 2023 Feb 1];3:250. Available from: https://www.ijoreports.in/text.asp?2023/3/1/250/368226
A 25-year-old woman with no known systemic diseases experienced sudden vision impairment in the left eye (Snellen VA 20/200). Fundus photography (A) and FA (B) at presentation demonstrated non-perfusion of the cilioretinal artery (arrow head, marked in yellow). Spectral domain optical coherence tomography (SD-OCT) (C) showed a hyper-reflective inner retinal layer because of ischemic damage (arrow). After intravitreal dexamethasone implant (Ozurdex®; Allergan Inc, Irvine, CA) injection in the left eye,, the vascular perfusion was gradually restored. At 10 weeks, the fundus photography (D) and FA (E) showed improvement of optic nerve swelling, reduction in vascular dilation, and a non-perfusion area (arrow head, marked in yellow). SD-OCT (F) demonstrated improvement of retinal ischemia (arrow) [Figure 1]. The patient's VA improved to 20/20.
|Figure 1: This figure demonstrates the resolution of cilioretinal artery occlusion with central retinal vein occlusion in the left eye of a 25-year-old patient|
Click here to view
Dexamethasone implant injection seemed to be effective in this single case, but further studies with more patients and longer follow-up are warranted in the future.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Garweg JG, Zandi S. Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment. Graefes Arch Clin Exp Ophthalmol 2016;254:1257-65.
Glacet-Bernard A, Sellam A, Coscas F, Coscas G, Souied EH. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: A new test for follow-up evaluation. Eur J Ophthalmol 2016;26:460-8.